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Gregory L. Moneta, MD, Section EditorAssociation Between Hospital Imaging Use and Venous
Thromboembolism Events Rates Based on Clinical Data
Ju MH, Chung JW, Kinnier CV, et al. Ann Surg 2014;260:558-66.
Conclusions: Venous thromboembolism (VTE) rates when exam-
ined with clinically ascertained outcomes and detailed risk adjustment reﬂect
hospital imaging rates and therefore perhaps are more of an indicator of vigi-
lant high-quality care and not poor performance.
Summary: The Centers for Medicare & Medicaid Services (CMS)
have declared VTE a “never event” that is not additionally reimbursed
following certain operations. VTE performance may also be eventually
tied to ﬁnancial penalties through the 2015 CMS Hospital Value-based Pur-
chasing program. However, the validity of VTE as a quality and safety indi-
cator has been questioned. There’s a real possibility of a co-called
surveillance bias or “the more you look, the more you ﬁnd”. It may be
that hospitals that are more vigilant and look more frequently for VTE
ﬁnd more VTE, and therefore are potentially penalized for having high
VTE rates. Using Medicare administrative claims data limited to patients
$65 years of age or older, the authors previously found evidence to support
this “the more you look, the more your ﬁnd” phenomenon (Bilimoria KY et
al, JAMA 2013;310:1482-9). However, such data was limited to the inpa-
tient period only and many VTE events may occur following hospitalization.
To address these limitations and to encompass a wider variety of patients,
the authors used data from the American College of Surgeons National Sur-
gical Quality Improvement Project (NSQIP) to further investigate the
“more you look, the more you ﬁnd” phenomenon with respect to VTE.
Data from 208 hospitals (2009 to 2010) were used for analysis. Hospitals
were divided into quartiles according to VTE imaging use rates (Medicare
claims). Observed and risk-adjusted postoperative VTE rates (regression
models using the NSQIP data) were examined across VTE imaging use
rate quartiles. Multivariable linear regression models were developed to
assess the impact of hospital characteristics (American Hospital Association)
and hospital imaging use rates on VTE event rates. The mean risk-adjusted
VTE event rates at 30 days after surgery increased across VTE imaging use
rate quartiles: 1.13% in the lowest quartile to 1.92% in the highest quartile
(P < .001). The trend was statistically signiﬁcant and remained when exam-
ining only the inpatient period. Hospital VTE imaging use rate was the
dominant driver of reported VTE event rates (P < .001). No other hospital
characteristics had signiﬁcant associations.
Comment: The data further cast doubt on the use of VTE rates as a
measure of hospital quality and as a valid patient safety indicator. Use of
VTE rates in pay-for-performance may have the unintended consequence
of decreasing VTE imaging rates and subsequent decreased treatment of
VTE because it is not discovered and as a consequence, worse patient
outcomes.Improved Quality of Life After 1 Year With an Invasive
Versus a Noninvasive Treatment Strategy in Claudicants:
One-Year Results of the Invasive Revascularization or
Not in Intermittent Claudication (IRONIC) Trial
Nordanstig J, Taft C, Hensäter M, et al. Circulation 2014;130:939-47.
Conclusions: An invasive treatment strategy improves intermittent
claudication (IC) distance and health-related quality of life at 1 year in pa-
tients with stable lifestyle-limiting claudication undergoing current medical
management.
Summary: Patients with IC have an increased risk of cardiovascular
events and premature death. In addition, it has been demonstrated that ex-
ercise therapy, particularly supervised exercise therapy, can improve symp-
toms. Therefore, the generally accepted ﬁrst line of treatment for patients
with IC is risk factor modiﬁcation and exercise training. However, super-
vised exercise training, likely the most effective form of exercise therapy, is
not available to many patients. It is also probably only cost effective when
health-related quality of life results are extrapolated beyond the end of
the existing trial data and under the assumption that activity-induced bene-
ﬁts will result in reduction of mortality and cardiovascular events. The
IRONIC trial is a prospective, randomized, controlled study to test the hy-
pothesis that an invasive treatment strategy vs continued noninvasive treat-
ment improves health-related quality of life after 1 year in unselected280patients with IC. Unselected patients with IC after clinical and duplex ultra-
sound assessment, requesting treatment for IC were randomly assigned to
invasive (n ¼ 79) or noninvasive (n ¼ 79) treatment groups. The primary
end point was health-related quality of life after 1 year, assessed with the
Medical Outcomes Study Short Form 36 version 1 and the Vascular Quality
of Life Questionnaire. Secondary end points included walking distance on a
graded treadmill. The SF 36 version 1 physical component summary (P <
.001) and Medical Outcomes Study short Form 36 version 1 physical sub-
scales improved signiﬁcantly more in the invasive vs the noninvasive treat-
ment group. Overall, vascular quality of life questionnaire score (P < .01)
in 3 of 5 domain scores improved signiﬁcantly more in the invasive vs nonin-
vasive treatment group. IC distance improved more in the invasive (+124m)
vs the noninvasive (+50 m) group (P ¼ .003). Change in maximum walking
distance was not signiﬁcantly different between groups. In the invasive
group both endovascular and open procedures were performed with 28 pro-
cedures above the inguinal ligament and 47 below the inguinal ligament. At
1 year, ankle-brachial index and toe pressures were higher in the invasive vs
noninvasive group. Event free survival at 12 months was 77% in invasive vs
88% in the noninvasive group.
Comment: The study results cannot be generalized to patients with
mild or very severe symptoms. In addition, patients in the noninvasive group
received only advised exercise and a structured but not a supervised pro-
gram. Therefore, one may argue that optimal treatment was not provided
to the noninvasive group although perhaps it is real world treatment. In
addition, the number of patients was too small to perform subgroup analysis
on the effect of open vs endovascular treatments and above and below the
inguinal ligament treatments on health quality of life parameters. However
while it is unclear as to the magnitude of beneﬁt with the invasive treatment
strategy, it does not appear that the patients were harmed to a signiﬁcant
extent, at least in this study out to 1 year.The Impact of Acute Renal Failure on Early and Late
Outcomes After Thoracic Aortic Endovascular Repair
Drews JD, Patel HJ, Williams DM, et al. Ann Thorac Surg 2014;97:2027-33.
Conclusions: Acute kidney injury (AKI) is an important risk factor for
both early and late mortality following thoracic aortic endovascular repair
(TEVAR).
Summary: Acute kidney injury (AKI) is a well-known and impor-
tant source of morbidity after thoracic aortic surgery. Most of the debate
however has been derived from open thoracic aortic repair, and there is
limited and conﬂicting data on the frequency of AKI following TEVAR.
The authors note that a recently popularized concensus criteria termed
RIFLE (Risk-injury, failure, loss, end-stage) is a consistent standard by
which to evaluate perioperative renal insufﬁciency (Bellomo R et al,
Intensive Care Med 2007; 33:409-13). The purpose of this study there-
fore was to review the incidence and risk factors that impact AKI occur-
ring after TEVAR over a 20-year period. There were 350 patients
without prior dialysis requirement who underwent TEVAR (1993 to
2013). Mean age was 68.7 years (54% male). The mean preoperative
glomerular ﬁltration rate was 76.5 6 37.6 mL/min, with 39 patients
(11.7%) in chronic kidney disease stage 3 or 4. TEVAR was performed
for rupture in 20.6%. Mean contrast volume administered was 95.7 6
52.9 ml. 4.9% of patients (n ¼ 17) had early mortality. AKI deﬁned as
RIFLE classes risk, injury or failure was seen in 59 (17%) patients (risk
¼ 36, injury ¼ 14, failure ¼ 9). Independent predictors of AKI included
history of a saccular aneurysm, presentation with rupture, or need for
arch repair or red blood cell transfusion (all P < .05). Only two patients
(0.6%) required postoperative dialysis, and none required permanent
dialysis. Ten-year freedom from dialysis was 97.7%. Development of
AKI predicted early mortality (P < .001, odds ratio 9.8). Ten-year sur-
vival was 38.1%. Both injury and failure AKI RIFLE classes indepen-
dently predicted late mortality (P < .05). Length of stay was markedly
increased with occurrence of AKI (mean, 16.8 6 15.5 days vs no AKI,
6.6 6 6.0 days; P < .001). Occurrence of renal failure was also indepen-
dently associated with an increased risk of late mortality and when strat-
iﬁed by class of AKI both the injury and the failure stages independently
predicted late mortality (injury odds ratio, 4.0, P < .001; failure odds ra-
tio, 2.8; P ¼ .039).
